Status:

UNKNOWN

Evaluation of a Synbiotic Formula in Patient With COVID-19

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Coronavirus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A series of microbiota were correlated inversely with the disease severity and virus load. Gut microbiota could play a role in modulating host immune response and potentially influence disease severit...

Detailed Description

Coronavirus can target multiple organs due to the hyperactive immune response with cytokine storms. Several studies have detected SARS-CoV-2 in stool samples and indicated that the virus could spread ...

Eligibility Criteria

Inclusion

  • Aged 18 or above; and
  • A confirmed diagnosis of SARS-Cov.2 infection using the PCR according to the standard of according to Centre for Health Protection, Department of Health, HK and released from isolation at recruitment.
  • Written informed consent obtained

Exclusion

  • Known allergy or intolerance to the intervention product or its components
  • Any known medical condition that would prevent taking oral probiotics or increase risks associated with probiotics including but not limited to inability to swallow/aspiration risk and no other methods of delivery (e.g., no G/J tube)
  • Known increased infection risk due to immunosuppression such as:
  • Prior organ or hematopoietic stem cell transplant
  • Neutropenia (ANC \<500 cells/ul)
  • HIV and CD4 \<200 cells/ul
  • Known increased infection risk due to endovascular due to:
  • Rheumatic heart disease
  • Congenital heart defect,
  • Mechanical heart valves
  • Endocarditis
  • Endovascular grafts
  • Permanent endovascular devices such as permanent (not short-term) hemodialysis catheters, pacemakers, or defibrillators
  • Documented pregnancy

Key Trial Info

Start Date :

August 25 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04730284

Start Date

August 25 2020

End Date

March 31 2022

Last Update

January 29 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chinese University of Hong Kong

Hong Kong, Hong Kong